Cite
MLA Citation
Lars Ryttberg et al.. “Cost–effectiveness of rivaroxaban versus heparins for prevention of venous thromboembolism after total hip or knee surgery in Sweden.” Expert review of pharmacoeconomics & outcomes research, vol. 11, 2011, pp. 601–615. http://access.bl.uk/ark:/81055/vdc_100125142180.0x000006